YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
LifeMD, Inc. (NASDAQ:LFMD) announced an exclusive healthcare collaboration on September 15 that initially makes virtual-health membership benefits available to approximately 29 million eligible AT&T wireless and fiber customers across 11 s…
AT&T (NYSE:T) has introduced Cricket 5G Home Internet, extending fixed wireless broadband over its existing 5G network for Cricket Wireless customers. The telecom group has partnered with LifeMD to provide eligible AT&T subscribers with fr…
AT&T Inc. T has added new healthcare benefits for its eligible wireless and fiber customers through a partnership with LifeMD, Inc. LFMD, offering complimentary access to virtual care and pharmacy services. The collaboration expands AT&T's…
DALLAS, Sept. 15, 2026 /PRNewswire/ --AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD Through an exclusive collaboration with LifeMD, eligible AT&T wireless and fiber customers receive a…
UPDATE this press release has been updated to remove a duplicate table. Second quarter 2026 revenue of $47.3 million, within the Company’s guidance range of $47 million to $50 million; adjusted EBITDA loss of approximately $3.5 million, im…
NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close…
Hims & Hers Health, Inc. HIMS continues to strengthen its position as a vertically integrated virtual-care platform by combining technology, provider networks, pharmacy infrastructure and recurring patient relationships into a unified heal…
Cardinal Health CAH is increasingly positioning itself as a foundational layer of the U.S. healthcare system, leveraging scale, operational reliability and integrated capabilities to deepen its role across pharmaceutical distribution, spec…
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming investor conferences. LD Micro Invitational…
LifeMD logo Key Points Q1 results: LifeMD reported revenue of $50.2 million, beating guidance, and added a record >42,000 net telehealth subscribers to finish with over 365,000, while front‑loaded marketing drove a GAAP net loss of $9.6 mi…
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This…
Image source: The Motley Fool. DATE Wednesday, May 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Justin Schreiber Chief Financial Officer — Atul Kavikar Need a quote from a Motley Fool analyst? Email pr@fool.com Full…
Image source: The Motley Fool. DATE Wednesday, May 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Justin SchreiberChief Financial Officer — Atul Kavikar Need a quote from a Motley Fool analyst? Email pr@fool.com TAKEAW…
Hims & Hers Health, Inc. HIMS has built its business around a digital, direct-to-consumer (DTC) platform that reimagines how patients access healthcare. At its core, the company enables customers to discover, consult, receive prescriptions…
LifeMD, Inc. LFMD shares ended the last trading session 23.7% higher at $5.06. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 4.9% gain over the…
The market has shown impressive growth, with a 4.2% increase over the last week and a 29% rise over the past year, while earnings are projected to grow by 16% annually. Although the term 'penny stock' may seem outdated, it still represents…
Hims & Hers Health, Inc. HIMS has built its model around a tightly integrated digital platform that connects patients with licensed healthcare providers while managing the full care journey end-to-end. Its services combine telehealth consu…
LifeMD, Inc. LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- LifeMD,…
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) is stepping up its push to regain share in the obesity drug market, introducing a subscription-based pricing model that could improve access and pricing visibility for cash-…
LifeMD, Inc. Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD’s collaboration with Novo Nordisk NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of vir…
The company is trying to win customers by offering a “lower, predictable monthly price” for its Wegovy obesity drugs. Continue Reading
New subscription-based option helps eligible self-pay patients start and stay on Wegovy® with predictable pricing Available March 31, 2026, through Ro, WeightWatchers, LifeMD, with Hims & Hers, Sesame, and other telehealth providers coming…
Cardinal Health CAH is clearly benefiting from the rapid adoption of GLP-1 therapies, though the impact remains more pronounced on revenues than profitability. In the second quarter of fiscal 2026, GLP-1 drugs contributed approximately six…
Renowned health and wellness platform, Hims & Hers Health, Inc. HIMS is fundamentally built as a consumer-first digital health platform that uses technology to reconfigure how care is accessed, delivered and experienced. At its core, the c…
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses lately. However, the stock is currently experiencing an uptrend in its price performance. The San Francisco, CA-based health and wellness platform’s st…
[Patient at home while on video conference call with Doctor] Courtney Hale/E+ via Getty Images LifeMD (LFMD [https://seekingalpha.com/symbol/LFMD]) was soaring on Tuesday after Cantor Fitzgerald reportedly reiterated its Overweight rating…
(RTTNews) - Shares of LifeMD Inc. (LFMD), a telehealth company, are up over 5% at $3.30 in the premarket today, following its fourth quarter and full-year 2025 financial results. In addition, the firm provided revenue guidance for the firs…
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, built its business around a consumer-first, digitally native healthcare platform that delivers personalized care across a growing range of conditions through telehea…
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the cl…
Medifast logo Key Points Leadership transition: CEO Dan Chard will step down as CEO effective June 1, 2026 (remaining chairman) with President Nick Johnson expected to assume the CEO role, as the company repositions from a weight‑loss focu…
NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of LifeMD, Inc. (NASDAQ: LFMD) breached their fiduciary duties to shareholders. Accordi…
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, operates at the intersection of healthcare and proprietary technology by positioning its digital platform as the core engine of care delivery rather than a simple te…
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Beauty Stocks to Buy Right Now.BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS) TheFly reported on January 8, 2026, that BofA reduced the price target for Him…
(RTTNews) - Several biotech and healthcare names posted notable gains in after-hours trading on Friday, with investors showing renewed interest in companies tied to drug development, healthcare services, and financing updates. Zentalis Pha…
Novo Nordisk (NVO) stock extended gains on Friday after the pharmaceutical giant announced a partnership with Amazon Pharmacy for its FDA-approved oral weight-loss pill. According to its press release, Amazon Pharmacy will offer access to…
Novo Nordisk has now launched the FDA-approved Wegovy oral GLP-1 pill across more than 70,000 U.S. pharmacies and telehealth channels, offering a once-daily option for chronic weight management and cardiovascular risk reduction alongside d…